Vis enkel innførsel

dc.contributor.authorOmsland, Mariaen_US
dc.contributor.authorPise-Masison, Cynthia A.en_US
dc.contributor.authorFujikawa, Daien_US
dc.contributor.authorGalli, Veronicaen_US
dc.contributor.authorFenizia, Claudioen_US
dc.contributor.authorParks, Robyn Washingtonen_US
dc.contributor.authorGjertsen, Bjørn Toreen_US
dc.contributor.authorFranchini, Genoveffaen_US
dc.contributor.authorAndresen, Vibekeen_US
dc.date.accessioned2019-07-05T13:51:31Z
dc.date.available2019-07-05T13:51:31Z
dc.date.issued2018-07-24
dc.PublishedOmsland M, Pise-Masison CA, Fujikawa, Galli V, Fenizia, Parks RW, Gjertsen BT, Franchini G, Andresen V. Inhibition of tunneling nanotube (TNT) formation and Human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabine. Scientific Reports. 2018;8:11118eng
dc.identifier.issn2045-2322
dc.identifier.urihttps://hdl.handle.net/1956/20571
dc.description.abstractThe human T-cell leukemia virus type 1 (HTLV-1) is highly dependent on cell-to-cell interaction for transmission and productive infection. Cell-to-cell interactions through the virological synapse, bioflm-like structures and cellular conduits have been reported, but the relative contribution of each mechanism on HTLV-1 transmission still remains vastly unknown. The HTLV-1 protein p8 has been found to increase viral transmission and cellular conduits. Here we show that HTLV-1 expressing cells are interconnected by tunneling nanotubes (TNTs) defned as thin structures containing F-actin and lack of tubulin connecting two cells. TNTs connected HTLV-1 expressing cells and uninfected T-cells and monocytes and the viral proteins Tax and Gag localized to these TNTs. The HTLV-1 expressing protein p8 was found to induce TNT formation. Treatment of MT-2 cells with the nucleoside analog cytarabine (cytosine arabinoside, AraC) reduced number of TNTs and furthermore reduced TNT formation induced by the p8 protein. Intercellular transmission of HTLV-1 through TNTs provides a means of escape from recognition by the immune system. Cytarabine could represent a novel anti-HTLV-1 drug interfering with viral transmission.en_US
dc.language.isoengeng
dc.publisherNature Researcheng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/eng
dc.titleInhibition of tunneling nanotube (TNT) formation and Human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabineen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2019-01-24T11:24:28Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2018 The Authors
dc.identifier.doihttps://doi.org/10.1038/s41598-018-29391-w
dc.identifier.cristin1603569
dc.source.journalScientific Reports


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY